Cleared Traditional

K842741 - GILL HEMATOXYLIN STAIN (FDA 510(k) Clearance)

Class I Pathology device.

K842741 · E K Ind., Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1984
Decision
33d
Days
Class 1
Risk

K842741 is an FDA 510(k) clearance for the GILL HEMATOXYLIN STAIN. Classified as Hematoxylin (product code HYJ), Class I - General Controls.

Submitted by E K Ind., Inc. (Mchenry, US). The FDA issued a Cleared decision on August 15, 1984 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.1850 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E K Ind., Inc. devices

Submission Details

510(k) Number K842741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 1984
Decision Date August 15, 1984
Days to Decision 33 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 77d · This submission: 33d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HYJ Hematoxylin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.1850
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.